» Articles » PMID: 20377363

Mathematical Spatio-temporal Model of Drug Delivery from Low Temperature Sensitive Liposomes During Radiofrequency Tumour Ablation

Overview
Publisher Informa Healthcare
Specialties Oncology
Pharmacology
Date 2010 Apr 10
PMID 20377363
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Studies have demonstrated a synergistic effect between hyperthermia and chemotherapy, and clinical trials in image-guided drug delivery combine high-temperature thermal therapy (ablation) with chemotherapy agents released in the heating zone via low temperature sensitive liposomes (LTSL). The complex interplay between heat-based cancer treatments such as thermal ablation and chemotherapy may require computational models to identify the relationship between heat exposure and pharmacokinetics in order to optimise drug delivery.

Materials And Methods: Spatio-temporal data on tissue temperature and perfusion from heat-transfer models of radiofrequency ablation were used as input data. A spatio-temporal multi-compartmental pharmacokinetic model was built to describe the release of doxorubicin (DOX) from LTSL into the tumour plasma space, and subsequent transport into the extracellular space, and the cells. Systemic plasma and tissue compartments were also included. We compared standard chemotherapy (free-DOX) to LTSL-DOX administered as bolus at a dose of 0.7 mg/kg body weight.

Results: Modelling LTSL-DOX treatment resulted in tumour tissue drug concentration of approximately 9.3 microg/g with highest values within 1 cm outside the ablation zone boundary. Free-DOX treatment produced comparably uniform tissue drug concentrations of approximately 3.0 microg/g. Administration of free-DOX resulted in a considerably higher peak level of drug concentration in the systemic plasma compartment (16.1 microg/g) compared to LTSL-DOX (4.4 microg/g). These results correlate well with a prior in vivo study.

Conclusions: Combination of LTSL-DOX with thermal ablation allows localised drug delivery with higher tumour tissue concentrations than conventional chemotherapy. Our model may facilitate drug delivery optimisation via investigation of the interplays among liposome properties, tumour perfusion, and heating regimen.

Citing Articles

Lipid Nanoparticles-Based Therapy in Liver Metastasis Management: From Tumor Cell-Directed Strategy to Liver Microenvironment-Directed Strategy.

Wang Y, Yin Z, Gao L, Ma B, Shi J, Chen H Int J Nanomedicine. 2023; 18:2939-2954.

PMID: 37288351 PMC: 10243353. DOI: 10.2147/IJN.S402821.


Review of the Delivery Kinetics of Thermosensitive Liposomes.

Haemmerich D, Ramajayam K, Newton D Cancers (Basel). 2023; 15(2).

PMID: 36672347 PMC: 9856714. DOI: 10.3390/cancers15020398.


Selecting ideal drugs for encapsulation in thermosensitive liposomes and other triggered nanoparticles.

Ramajayam K, Newton D, Haemmerich D Int J Hyperthermia. 2022; 39(1):998-1009.

PMID: 35876089 PMC: 9774053. DOI: 10.1080/02656736.2022.2086303.


Extracorporeal Removal of Thermosensitive Liposomal Doxorubicin from Systemic Circulation after Tumor Delivery to Reduce Toxicities.

Motamarry A, Wolfe A, Ramajayam K, Pattanaik S, Benton T, Peterson Y Cancers (Basel). 2022; 14(5).

PMID: 35267630 PMC: 8909191. DOI: 10.3390/cancers14051322.


Computational Modeling of Combination of Magnetic Hyperthermia and Temperature-Sensitive Liposome for Controlled Drug Release in Solid Tumor.

Tehrani M, Soltani M, Moradi Kashkooli F, Mahmoudi M, Raahemifar K Pharmaceutics. 2022; 14(1).

PMID: 35056931 PMC: 8778939. DOI: 10.3390/pharmaceutics14010035.


References
1.
Barauskas R, Gulbinas A, Vanagas T, Barauskas G . Finite element modeling of cooled-tip probe radiofrequency ablation processes in liver tissue. Comput Biol Med. 2008; 38(6):694-708. DOI: 10.1016/j.compbiomed.2008.03.007. View

2.
Qian F, Saidel G, Sutton D, Exner A, Gao J . Combined modeling and experimental approach for the development of dual-release polymer millirods. J Control Release. 2002; 83(3):427-35. DOI: 10.1016/s0168-3659(02)00217-1. View

3.
Brizel D, Klitzman B, Cook J, Edwards J, Rosner G, Dewhirst M . A comparison of tumor and normal tissue microvascular hematocrits and red cell fluxes in a rat window chamber model. Int J Radiat Oncol Biol Phys. 1993; 25(2):269-76. DOI: 10.1016/0360-3016(93)90348-y. View

4.
Wu N, Da D, Rudoll T, Needham D, Whorton A, Dewhirst M . Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue. Cancer Res. 1993; 53(16):3765-70. View

5.
Poon R, Borys N . Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer. Expert Opin Pharmacother. 2009; 10(2):333-43. DOI: 10.1517/14656560802677874. View